Clinical trial · Observational
HPV Infection, Sexually Transmitted Infections and Anal Dysplasia in the Transgender Population
Prevalence of Genital, Anal and Oral HPV Infection and Sexually Transmitted Infections, and of Anal Dysplasia in the Transgender Population (PrevHPV-TG)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this observational study is to estimate the prevalence of HPV infections anal and ENT level and according to HIV status in transgender (TG) population. The main question it aims to answer is: * What is the prevalence of HPV lesions in transgender population (TG); * What kind of high risk HPV (hrHPV) and low risk HPV (lrHPV) are detected at the genital, anal and ENT level
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Human Immunodeficiency Virus Infection | — | UNRESOLVED | — |
| Human Papillomavirus Infection | — | UNRESOLVED | — |
| Sexually Transmitted Diseases | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- Transgender population
- description
- Cohort of transgender people (man to woman and woman to man)
Primary outcomes (1)
- measure
- Prevalence of HPV infection in transgender population
- timeFrame
- 12 months
- description
- The prevalence of HPV infections is defined as the percentage of subjects with HPV infection among transgender people included, regardless the site of infection.
Secondary outcomes (6)
- measure
- Prevalence of HPV infections at the genital, anal and ENT level and according to HIV status
- timeFrame
- 12 months
- description
- We will estimate the prevalence of HPV infections in each anatomical site (genital, anal and ENT) and according to HIV status.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion criteria: * Age ≥ 18 years * To belong to transgender population : i.e. people who doesn't identify to the gender assigned at birth * To be affiliated to a social security system or be beneficiary of AME Exclusion criteria: * To have ever been vaccinated against HPV * Research participation refusal * People under guardianship or curatorship, or deprived of liberty by administrative or judiciary measure
References
Publications (0)
Data not yet available